Loading clinical trials...
Loading clinical trials...
Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility (RESCU). An Analysis of Clinical Outcomes and Left Ventricular Recovery of STEMI Patients Treated With SSO2 Therapy After Primary Percutaneous Coronary Intervention (PPCI)
Conditions
Locations
8
United States
Baptist Hospital of Miami, Inc and Its Miami Cardiac and Vascular Institute
Miami, Florida, United States
NCH Healthcare System
Naples, Florida, United States
Oakwood Healthcare, Inc
Dearborn, Michigan, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
Northwell Health, Inc
Great Neck, New York, United States
OhioHealth Research Institute
Columbus, Ohio, United States
Start Date
July 31, 2023
Primary Completion Date
February 28, 2024
Completion Date
March 31, 2024
Last Updated
April 4, 2024
NCT02943954
NCT02914795
NCT01986803
Lead Sponsor
Cardiovascular Research Foundation, New York
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions